<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02268357</url>
  </required_header>
  <id_info>
    <org_study_id>NL42210.018.13</org_study_id>
    <nct_id>NCT02268357</nct_id>
  </id_info>
  <brief_title>The Effects of Propranolol on Fear of Tooth or Molar Extraction</brief_title>
  <official_title>Effects of Propranolol on Fear of Dental Extraction: Study Protocol for a Randomized Placebo-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, placebo-controlled, double-blind, parallel group clinical trial evaluating the
      anxiolytic effects of propranolol on fear of wisdom tooth removal. It is hypothesized that,
      compared to placebo, perioperative oral propranolol reduces dental trait anxiety at 1 month
      follow-up after wisdom tooth removal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RATIONALE Tooth and molar removals are among the most feared interventions in dentistry and
      oral and maxillofacial surgery (OMFS). Anxiety for these procedures not only produces
      discomfort to the patient, but may also induce patient behavior that impedes surgery, thereby
      increasing operative time and complicating postoperative recovery. In addition, it has been
      found that having undergone an extraction poses a significantly increased risk for developing
      chronic apprehension for dental surgical procedures, disproportionate forms of dental anxiety
      (i.e., dental phobia), and symptoms of post-traumatic stress. Addressing these problems
      effectively requires an intervention that reduces both state anxiety during surgery and
      dental trait anxiety in the long term.

      OBJECTIVE The purpose of this trial is to determine the anxiolytic effects of the
      ß-adrenoreceptor antagonist propranolol on patients with high levels of fear in anticipation
      of dental extraction.

      METHODS Trial design: Randomized, placebo-controlled, two-group, parallel, double-blind,
      single center trial of 34 participants. Population and recruitment: Consecutive patients,
      referred by their dentist to the department of Oral and Maxillofacial Surgery of the Academic
      Medical Center of the University Amsterdam, for at least two tooth and/or molar removals,
      with self-reported high to extreme fear in anticipation of dental extraction. Intervention:
      Two 40 mg propranolol capsules one hour prior to dental extraction, followed by one 40 mg
      capsule directly postoperatively. Comparator: Placebo capsules. Primary outcome: Dental trait
      anxiety score reduction from baseline to 4-weeks follow-up. Secondary outcomes: Self-reported
      anxiety during surgery; physiological parameters (heart rate and blood pressure) during
      recall of the crucial fear-related memory; self-reported vividness and emotional charge of
      the crucial fear-related memory.

      RISKS AND BENEFITS ASSOCIATED WITH PARTICIPATION Participants of the trial will undergo
      regular dental extraction procedures (treatment as usual), with an additional potentially
      anxiolytic pharmacological intervention (propranolol) or placebo. The most important known
      side-effects of propranolol are mild and self-limiting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline at 1 month follow-up in Short version of the Dental Anxiety Inventory (S-DAI)</measure>
    <time_frame>Change from baseline at 1 month follow-up</time_frame>
    <description>dental trait anxiety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline at 1 month follow-up in Self-reported vividness and emotional charge of the crucial fear-related memory</measure>
    <time_frame>Change from Baseline at 1 month follow-up</time_frame>
    <description>Visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline at 1 month follow-up in State anxiety during treatment</measure>
    <time_frame>Change from Baseline at 1 month follow-up</time_frame>
    <description>Visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline at 1 month follow-up in Physiological parameters (heart rate and blood pressure) during recall of the crucial fear-related memory</measure>
    <time_frame>Change from Baseline at 1 month follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Dental Anxiety</condition>
  <arm_group>
    <arm_group_label>Propranolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>capsules PROPRANOLOL (study medication); 80 mg 1 hour preoperative; 40 mg directly postoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>capsules MICROCRYSTALLINE CELLULOSE (study medication); 80 mg 1 hour preoperative; 40 mg directly postoperative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propranolol</intervention_name>
    <description>Oral propranolol capsules</description>
    <arm_group_label>Propranolol</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>propranolol hydrochloride</other_name>
    <other_name>propranolol HCl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          1. Signed written informed consent

          2. ≥ 18 Years of age on entry to the study

          3. Self-reported high to extreme fear of tooth or molar removal

          4. Dutch or English-speaking

        Exclusion criteria

          1. Asthma or other obstructive pulmonary disease

          2. Cardiac failure

          3. Cardiac arrhythmia

          4. Renal failure

          5. Insulin-dependent diabetes mellitus

          6. Pregnant or breast-feeding

          7. Current use of another ß-adrenoreceptor antagonist

          8. Current use of anxiolytic or antidepressant medication

          9. Currently in psychotherapy for dental anxiety

         10. Systolic blood pressure &lt; 100 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>prof. dr. J. de Lange, MD, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academic Medical Center (AMC) of Amsterdam</affiliation>
  </overall_official>
  <overall_official>
    <last_name>prof. dr. A. de Jongh, DDS, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>prof. dr. J. de Lange, MD, DDS, PhD</last_name>
    <email>j.delange@amc.uva.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>S. A. Steenen, MD</last_name>
    <email>s.a.steenen@amc.uva.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Oral and Maxillofacial Surgery, Academic Medical Center, University of Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S. A. Steenen, MD</last_name>
      <email>s.a.steenen@amc.uva.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Liu HH, Milgrom P, Fiset L. Effect of a beta-adrenergic blocking agent on dental anxiety. J Dent Res. 1991 Sep;70(9):1306-8.</citation>
    <PMID>1918581</PMID>
  </reference>
  <reference>
    <citation>Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res. 2008 May;42(6):503-6. Epub 2007 Jun 22.</citation>
    <PMID>17588604</PMID>
  </reference>
  <reference>
    <citation>Lonergan MH, Olivera-Figueroa LA, Pitman RK, Brunet A. Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis. J Psychiatry Neurosci. 2013 Jul;38(4):222-31. doi: 10.1503/jpn.120111. Review.</citation>
    <PMID>23182304</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2014</study_first_submitted>
  <study_first_submitted_qc>October 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2014</study_first_posted>
  <last_update_submitted>August 10, 2016</last_update_submitted>
  <last_update_submitted_qc>August 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Prof. dr. J. de Lange</investigator_full_name>
    <investigator_title>prof. dr. J. de Lange (mandated sponsor/principal investigator)</investigator_title>
  </responsible_party>
  <keyword>Dental Anxiety</keyword>
  <keyword>Tooth Extraction</keyword>
  <keyword>Propranolol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propranolol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

